Global

COMUNICADO: Takeda y Cognition Kit presentan un estudio sobre tecnología digital ponible en pacientes de trastorno depresivo mayor (

Logo -- https://mma.prnewswire.com/media/606987/Takeda_Pharmaceuticals_Logo.jpg [https://mma.prnewswire.com/media/606987/Takeda_Pharmaceuticals_Logo.jpg] Imagen - https://mma.prnewswire.com/media/607051/Cognition_Kit_Logo.jpg [https://mma.prnewswire.com/media/607051/Cognition_Kit_Logo.jpg]

CONTACTO: CONTACTO: Cognition Kit Limited, Ben Fehnert, director, RickyDolphin, director, tel.: 01223 810 700, hello@cognitionkit.com; o TakedaPharmaceuticals U.S.A., Comunicaciones Corporativas, Roseanne Durril, tel.:1-224-554-1474, Roseanne.Durril@takeda.com

Sitio Web: http://www.takeda.us/

WhatsAppWhatsApp
FacebookFacebook
TwitterTwitter
Linkedinlinkedin
emailemail
imprimirprint